Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Publication year range
1.
Clinics (Sao Paulo) ; 73: e332, 2018 10 18.
Article in English | MEDLINE | ID: mdl-30365818

ABSTRACT

OBJECTIVES: Several compounds characterized by an olefin linkage conjugated to a carbonyl group have anti-inflammatory properties. The diuretic ethacrynic acid (EA) is a compound of this type. Herein, we tested the hypothesis that ethacrynic acid can modulate the development of ileus after bowel manipulation. METHODS: Groups (n=9) of male C57Bl/6 mice underwent surgical manipulation of the small intestine using a pair of cotton-tipped applicators (MAN). Control animals (CONT) did not undergo any surgical intervention or receive treatment. MAN mice were pre- and post-treated with four intraperitoneal doses of phosphate buffered saline (PBS), EA1 (1mg/kg per dose), or EA10 (10mg/kg per dose). Gastrointestinal transit of non-absorbable FITC-labeled dextran was assessed by gavaging the mice with the tracer 24h after operation and assessing FD70 concentration 120 min later in the bowel contents from the stomach, 10 equally long segments of small intestine, cecum, and two equally long segments of colon. The geometric center for the tracer was calculated for each animal. Expression of interleukin-6 (IL-6) and inducible nitric oxide synthase (iNOS) transcripts in the ileal muscularis propria was assessed using semiquantitative reverse transcriptase-polymerase chain reaction. RESULTS: In control animals, the mean (±SE) geometric center for the transit marker was 9.89±0.47, whereas it was 4.59±0.59 for PBS-treated animals (p<0.05 vs CONT). The geometric center for pre- post treatment with low (1mg/kg) and high (10mg/kg) doses of ethacrynic acid were 7.23±0.97 and 5.15±0.57, respectively. Compared to PBS, treatment with ethacrynic acid (1mg/kg) significantly decreased manipulation-induced IL-6 and iNOS mRNA expression in the wall of the small bowel. CONCLUSIONS: Pre- and post-treatment with ethacrynic acid ameliorates ileus and modulates inflammation in the gut wall induced by bowel manipulation.


Subject(s)
Ethacrynic Acid/pharmacology , Gastrointestinal Transit/drug effects , Ileus/pathology , Inflammation Mediators/antagonists & inhibitors , Interleukin-6/antagonists & inhibitors , Intestine, Small/drug effects , Nitric Oxide Synthase Type II/antagonists & inhibitors , Animals , Disease Models, Animal , Ileus/surgery , Intestine, Small/pathology , Male , Mice , Mice, Inbred C57BL , Postoperative Complications , Reverse Transcriptase Polymerase Chain Reaction
2.
Clinics ; Clinics;73: e332, 2018. graf
Article in English | LILACS | ID: biblio-974939

ABSTRACT

OBJECTIVES: Several compounds characterized by an olefin linkage conjugated to a carbonyl group have anti-inflammatory properties. The diuretic ethacrynic acid (EA) is a compound of this type. Herein, we tested the hypothesis that ethacrynic acid can modulate the development of ileus after bowel manipulation. METHODS: Groups (n=9) of male C57Bl/6 mice underwent surgical manipulation of the small intestine using a pair of cotton-tipped applicators (MAN). Control animals (CONT) did not undergo any surgical intervention or receive treatment. MAN mice were pre- and post-treated with four intraperitoneal doses of phosphate buffered saline (PBS), EA1 (1mg/kg per dose), or EA10 (10mg/kg per dose). Gastrointestinal transit of non-absorbable FITC-labeled dextran was assessed by gavaging the mice with the tracer 24h after operation and assessing FD70 concentration 120 min later in the bowel contents from the stomach, 10 equally long segments of small intestine, cecum, and two equally long segments of colon. The geometric center for the tracer was calculated for each animal. Expression of interleukin-6 (IL-6) and inducible nitric oxide synthase (iNOS) transcripts in the ileal muscularis propria was assessed using semiquantitative reverse transcriptase-polymerase chain reaction. RESULTS: In control animals, the mean (±SE) geometric center for the transit marker was 9.89±0.47, whereas it was 4.59±0.59 for PBS-treated animals (p<0.05 vs CONT). The geometric center for pre- post treatment with low (1mg/kg) and high (10mg/kg) doses of ethacrynic acid were 7.23±0.97 and 5.15±0.57, respectively. Compared to PBS, treatment with ethacrynic acid (1mg/kg) significantly decreased manipulation-induced IL-6 and iNOS mRNA expression in the wall of the small bowel. CONCLUSIONS: Pre- and post-treatment with ethacrynic acid ameliorates ileus and modulates inflammation in the gut wall induced by bowel manipulation.


Subject(s)
Animals , Male , Mice , Gastrointestinal Transit/drug effects , Interleukin-6/antagonists & inhibitors , Inflammation Mediators/antagonists & inhibitors , Ileus/pathology , Nitric Oxide Synthase Type II/antagonists & inhibitors , Ethacrynic Acid/pharmacology , Intestine, Small/drug effects , Postoperative Complications , Reverse Transcriptase Polymerase Chain Reaction , Ileus/surgery , Disease Models, Animal , Intestine, Small/pathology , Mice, Inbred C57BL
3.
Naunyn Schmiedebergs Arch Pharmacol ; 388(5): 531-8, 2015 May.
Article in English | MEDLINE | ID: mdl-25653124

ABSTRACT

Our previous study has shown that mangiferin (MGF), a glucosylxanthone from Mangifera indica, exerts gastrointestinal prokinetic action involving a cholinergic mechanism. Postoperative ileus (POI) is a temporary disturbance in gastrointestinal motility following surgery, and intestinal inflammatory response plays a critical role in the pathogenesis of POI. The present study investigated to know whether MGF having anti-inflammatory and prokinetic actions can ameliorate the intestinal inflammation and impaired gastrointestinal transit seen in the mouse model of POI. Experimental POI was induced in adult male Swiss mice by standardized small intestinal manipulation (IM). Twenty-four hours later, gastrointestinal transit was assessed by charcoal transport. MGF was administered orally 1 h before the measurement of GIT. To evaluate the inflammatory response, plasma levels of proinflammatory cytokines TNF-α, IL-1ß, IL-6, and chemokine MCP-1, and the myeloperoxidase activity, nitrate/nitrite level, and histological changes of ileum were determined in mice treated or not with MGF. Experimental POI in mice was characterized by decreased gastrointestinal transit and marked intestinal and systemic inflammatory response. MGF treatment led to recovery of the delayed intestinal transit induced by IM. MGF in ileum significantly inhibited the myeloperoxidase activity, a marker of neutrophil infiltration, and nitrate/nitrite level and reduced the plasma levels of TNF-α, IL-1ß, IL-6, and MCP-1 as well. MGF treatment ameliorates the intestinal inflammatory response and the impaired gastrointestinal motility in the mouse model of POI.


Subject(s)
Enterocolitis/prevention & control , Gastrointestinal Agents/therapeutic use , Gastrointestinal Motility/drug effects , Ileus/prevention & control , Postoperative Complications/prevention & control , Xanthones/therapeutic use , Animals , Cytokines/blood , Disease Models, Animal , Enterocolitis/etiology , Enterocolitis/immunology , Enterocolitis/pathology , Gastrointestinal Agents/administration & dosage , Gastrointestinal Agents/isolation & purification , Ileum/drug effects , Ileum/immunology , Ileum/pathology , Ileus/etiology , Ileus/immunology , Ileus/pathology , Male , Mangifera/chemistry , Mice , Plant Bark/chemistry , Plant Roots/chemistry , Postoperative Complications/etiology , Postoperative Complications/immunology , Postoperative Complications/pathology , Xanthones/administration & dosage , Xanthones/isolation & purification
4.
Univ. med ; 53(3): 297-308, jul.-sept. 2012. ilus
Article in Spanish | LILACS | ID: lil-682060

ABSTRACT

El íleo biliar es una patología poco común y de difícil diagnóstico prequirúgico, pues en la mayoría de los casos se presenta como obstrucción intestinal sin síntomas biliares asociados. En el artículo se presentan dos casos del 2010, cada uno con características diferentes respecto a la localización de la fístula y la evolución postoperatoria: una fístula colecistogástrica con obstrucción del íleon terminal y una fístula colecistoduodenal con obstrucción del yeyuno medio. En el primero se hizo una resolución del íleo biliar y en el mismo tiempo quirúrgico la colecistectomía y cierre de la fístula; mientras que en el otro se trató únicamente el cuadro obstructivo. Dado que en la literatura no existe una amplia revisión de esta situación clínica, no hay consenso en cuanto a la resolución de la patología biliar en el mismo tiempo quirúrgico. Por la evolución clínica de los pacientes tan diversa, se evaluó el problema...


Gallstone ileus is an uncommon pathology, difficultto diagnose on a pre-surgical way, mostly sometimespresents as intestinal obstruction withoutbiliary symptoms associated. In 2010, it presentedtwo cases, each one with different characteristicsregarding the fistula location and post-operativeevolution: cholecystogastric fistula and obstructionof the terminal ileus and cholecystoduodenalfistula and obstruction of the medial yeyunum.First was resolved with colecystectomy and fistulaclosure. The second was trated only by obstructionresolution. Since in literature there isn’t acomprehensive review of this type of pathology,there is not agreement in the management of thebiliary pathology at the same surgical time, andtaking in account the different evolution of ourtwo patients, is the reason that we were interestedin the evaluation of this problem...


Subject(s)
Cholecystectomy , Fistula , Ileus/diagnosis , Ileus/pathology , Intestinal Obstruction
5.
Rev Gastroenterol Mex ; 73(4): 231-4, 2008.
Article in Spanish | MEDLINE | ID: mdl-19666272

ABSTRACT

The surgical literature contains few reports about effects of hypothyroidism in patients with acute abdomen; has been reported that a glycoprotein infiltrate the lining of the bowel leading to denervation. We report the case of a woman with acute abdomen secondary to pyosalpynx with uncontrolled hypothyroidism postoperative complications.Hypothyroidism is called "big mimicker"because its clinic spectrum ranges from anasymptomatic subclinical condition to the rare,life-threatening myxedema coma, and thus can bea challenging diagnosis to make. Unrecognized hypothyroidism may lead to unnecessary surgery or even a potentially fatal outcome. A heightened awareness of this not so uncommon entity is mandatory


Subject(s)
Abdomen, Acute/pathology , Ileus/pathology , Myxedema/pathology , Abdomen, Acute/diagnostic imaging , Abdomen, Acute/etiology , Adult , Coma/etiology , Female , Humans , Hypothyroidism/complications , Hypothyroidism/diagnostic imaging , Ileus/diagnostic imaging , Ileus/etiology , Myxedema/complications , Myxedema/diagnostic imaging , Tomography, X-Ray Computed
6.
Rev Gastroenterol Mex ; 73(4): 235-8, 2008.
Article in Spanish | MEDLINE | ID: mdl-19666273

ABSTRACT

BACKGROUND: Gallstone ileus represents 0.06% of gallstone disease cases as a result of cholecystoenteric fistulae. The presentation is that of intestinal obstruction, the stone is most commonly impacted in the terminal ileum. OBJECTIVE: To present a case of a patient with intestinal obstruction due to a giant stone impacted in the proximal jejunum. CASE REPORT: A 47 year old women presented with abdominal pain, distention, nausea and vomiting.An upper endoscopy revealed a deep duodenal ulcer penetrated to the pancreas. She had partial relief with medical treatment. She was admitted to ourhospital because a new episode of abdominal pain.Physical examination revealed an abdomen with diffuse pain, low peristalsis, leukocytes of 12 000/mm3, neutrophils of 85%, plain abdominal x-ray with intestinal obstruction and pneumobilia, CT scan with intestinal obstruction, hyperdense image in the intestinal lumen and a transition level.Surgery was performed, a giant stone of 6 cm in size was found in the proximal jejunum, an enter olithotomy was performed with primary closure. CONCLUSIONS: Gallstone ileus is a rare condition ofa common disease. It is important in the differential diagnosis in elderly patients with intestinal obstruction. The aim of treatment is to relieve the intestinal obstruction by enterotomy and stone removal.


Subject(s)
Biliary Fistula/pathology , Gallstones/complications , Gallstones/pathology , Ileus/etiology , Ileus/pathology , Intestinal Fistula/pathology , Abdomen/pathology , Female , Humans , Intestinal Obstruction/etiology , Jejunum/pathology , Middle Aged , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL